Adragos Pharma has acquired Sanofi’s Maisons-Alfort sterile fill-finish site in France, expanding its European manufacturing network and prefilled syringe capabilities.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
The newly constructed Verbund site in Zhanjiang, Guangdong Province in southern China, with an area of around four square kilometers, is more than just a major project for BASF in the growth market of China.
Connecting cost-advantaged production, technology leadership, access to global markets, and disciplined capital allocation to upgrade portfolio.
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
In this interview, industry experts explain why cell line development timelines are governed by biology—and how the focus is shifting from time compression to smarter optimization.
At CPhI Frankfurt, Christene Smith of CHEManager International interviews Axplora CCO Arul Ramadurai on navigating industry uncertainty and building strategic partnerships.
Kenyan start-up Zuripacks produces durable yet biodegradable packaging materials from banana pseudostems − an abundant agricultural by-product that is typically discarded.
The chemical industry's workforce is rapidly approaching retirement age. We need fresh talent, fast.
Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Ice Pharma recently announced a strategic expansion beyond its core API business, positioning the company to compete in higher-value finished dosage, nutraceutical, and specialty excipient markets.
First Clariant facility in the United States to manufacture pharmaceutical-grade polyethylene glycol excipients for oral and topical applications.
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
The Cleantech water technology company Blue Activity has completed an €8.5 million seed financing round.
“Enough with the Snail’s Pace!”: Industry Leaders Urge Action to Save Europe’s Chemical Sector
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
New $130 million facility in Jealott’s Hill, UK, to focus on next-generation, sustainable solutions for farming.
Arkema will increase Kynar PVDF production capacity at its Changshu, China site by 20% by 2028 to meet strong demand for batteries, coatings and other high-performance applications in Asia-Pacific and globally.
Sandoz has announced the creation of a new biosimilar development, manufacturing and supply unit.
Symbiosis Pharmaceutical Services has appointed experienced commercial leader Joanne Anderson as Chief Commercial Officer to drive global growth following recent capacity investments and expansion plans.
WeylChem will discontinue production at its Elgin, USA site and has established a new US sales office led by Cameron Young, Sales and New Business Development Director.
The IMCD Group has appointed Hedwig Koopmans as Managing Director of IMCD Switzerland with effect from April 1, 2026.
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Metrohm USA opened its new 15,000 sq ft Houston facility on March 24, 2026, marking its shift from leased space to a custom-built, sustainable site supporting technical innovation, training, and regional growth.
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.
Expansion boosts supply capabilities of dispersions for architectural coatings, construction and paper industries in East, West and Southern Africa.
Early CMC decisions determine success. Learn how structured planning and enabling technologies accelerate small-molecule programs to the clinic.
Partnership targets scaling up zeolite catalysts for commercial biofuel production.
Thyssenkrupp Uhde has been contracted by Halifax-based Nova Sustainable Fuels (NSF) to conduct an integration and optimization study for NSF's biomass-to-methanol project in Nova Scotia, Canada.
Kearney's 2026 Chemicals Executive M&A Report forecasts strengthened global deal activity after 2025 gains, with executives anticipating more small-to-mid-size transactions.
Cabot Corporation is establishing new Asia-Pacific production capabilities for circular reinforcing carbons using its Evolve Sustainable Solutions technology platform for more sustainable tire and rubber applications.
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
